![Mathew Smith](https://profiles-cardiff.imgix.net/attachments/2960?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr Mathew Smith
Teams and roles for Mathew Smith
Overview
Roles within the School, College and University
- Director of Learning and Teaching
- Chair, Undergraduate Board of Studies
- Chair, Programme Management Group
- Member, OSCE steering group
- Member, Board of Studies and Board of Examiners for the MPharm programme
- Member, UCAS Admissions Interview Team
- Member, MPharm Personal Development Portfolio Team
- Member, Postgraduate Research Board of Studies
- Member, College Interprofessional Education Special Interest Group, BLS College.
- Member, College Virtual Learning Environment Group
- Member, Learning, Teaching and Assessment committee
- Member, MPharm Assessment Strategy Implementation Group
News
GPhC appoints Dr Mathew Smith as a new pharmacist member to it's BoA - July 2016
Cost-saving tool improves treatment for care home patients - January 2016
External Roles
- General Pharmaceutical Council Board of Assessors. Member (co-opted)
- Royal Pharmaceutical Society Wales Care Homes Policy Group. Member
- Modernising Pharmacy Careers Wales Board. Member
- Chair, Modernising Pharmacy Careers Wales Workstream 1. Initial Education and Training Curriculum Design Group
- Public engagement: STEM ambassador
Qualifications
- MPharm, Welsh School of Pharmacy, Cardiff, 2002
- PhD, Cardiff University, 2009
Professional memberships
- General Pharmaceutical Council
- Royal Pharmaceutical Society
- Fellow of the Higher Education
Publication
2026
- Jones, E. et al. 2026. The role of social workers in medicines management for older adults: Insights from Wales. The British Journal of Social Work 56 (2), pp.629-649. (10.1093/bjsw/bcaf291)
2024
- Rawlings, A. et al., 2024. The burden of acute eye conditions on different healthcare providers: a retrospective population-based study. British Journal of General Practice 74 , pp.e264-e274. (10.3399/BJGP.2022.0616)
2021
- Orayj, K. et al. 2021. Factors affecting the choice of first-line therapy in Parkinson's disease patients in Wales: A population-based study. Saudi Pharmaceutical Journal 29 (2), pp.206-212. (10.1016/j.jsps.2021.01.004)
2019
- Orayj, K. et al. 2019. Association between levodopa and ischemic heart disease. International Journal of Population Data Science 4 (3) 011. (10.23889/ijpds.v4i3.1172)
2017
- Johnson, I. et al. 2017. Learning how "professions can work together to provide the best care": Dental-pharmacy inter-professional education presenter. Presented at: Learning together to improve oral health and quality of life Vilnius, Lithuania 23-26 August 2017. , pp.45-45.
- De Vis, P. et al., 2017. Herschel-ATLAS: revealing dust build-up and decline across gas, dust and stellar mass selected samples – I. Scaling relations. Monthly Notices of the Royal Astronomical Society 464 (4), pp.4680-4705. (10.1093/mnras/stw2501)
2016
- Jenkins, A. I. et al. 2016. Too far away to work with each other: Does location impact on pharmacists' perceptions of interprofessional interactions?. Journal of Interprofessional Care 30 (5), pp.678-681. (10.1080/13561820.2016.1191451)
2015
- Aljayyoussi, G. et al., 2015. Absorption of ipratropium and L-carnitine into the pulmonary circulation of the ex-vivo rat lung is driven by passive processes rather than active uptake by OCT/OCTN transporters. International Journal of Pharmaceutics 496 (2), pp.834-841. (10.1016/j.ijpharm.2015.10.036)
2013
- Aljayyoussi, G. et al. 2013. Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: A study in ex vivo lung models using chemical inhibition and genetic knockout. Journal of Pharmaceutical Sciences 102 (9), pp.3382-3394. (10.1002/jps.23587)
- Campbell, L. et al. 2013. Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease. Journal of Translational Medicine 11 (1) 255. (10.1186/1479-5876-11-255)
2012
- Smith, M. W. , Aljayyoussi, G. and Gumbleton, M. 2012. Peptide sequences mediating tropism to intact blood-brain barrier: An in vivo biodistribution study using phage display. Peptides 38 (1), pp.172-180. (10.1016/j.peptides.2012.06.019)
2011
- Gumbleton, M. et al. 2011. Spatial expression and functionality of drug transporters in the intact lung: objectives for further research. Advanced Drug Delivery Reviews 63 (1-2), pp.110-118. (10.1016/j.addr.2010.09.008)
- Morris, C. J. et al. 2011. Enhanced pulmonary absorption of a macromolecule through coupling to a sequence-specific phage display-derived peptide. Journal of Controlled Release 151 (1), pp.83-94. (10.1016/j.jconrel.2010.12.003)
- Smith, M. W. , Birchall, J. C. and Coulman, S. 2011. The wider contribution of microbiology to the pharmaceutical sciences. In: Denver, S. P. et al., Hugo and Russell's Pharmaceutical Microbiology 8th Edition. Wiley-Blackwell. , pp.463-482.
2009
- Smith, M. W. 2009. Phage display and experimental brain therapeutics. PhD Thesis , Cardiff University.
2007
- Barar, J. et al., 2007. Cell selective glucocorticoid induction of caveolin-1 and caveolae in differentiating pulmonary alveolar epithelial cell cultures. Biochemical and Biophysical Research Communications 359 (2), pp.360-366. (10.1016/j.bbrc.2007.05.106)
- Smith, M. W. , Omidi, Y. and Gumbleton, M. 2007. Primary porcine brain microvascular endothelial cells: Biochemical and functional characterisation as a model for drug transport and targeting. Journal of Drug Targeting 15 (4), pp.253-268. (10.1080/10611860701288539)
2006
- Smith, M. W. and Gumbleton, M. 2006. Endocytosis at the blood-brain barrier: From basic understanding to drug delivery strategies. Journal of Drug Targeting 14 (4), pp.191-214. (10.1080/10611860600650086)
Articles
- Jones, E. et al. 2026. The role of social workers in medicines management for older adults: Insights from Wales. The British Journal of Social Work 56 (2), pp.629-649. (10.1093/bjsw/bcaf291)
- Rawlings, A. et al., 2024. The burden of acute eye conditions on different healthcare providers: a retrospective population-based study. British Journal of General Practice 74 , pp.e264-e274. (10.3399/BJGP.2022.0616)
- Orayj, K. et al. 2021. Factors affecting the choice of first-line therapy in Parkinson's disease patients in Wales: A population-based study. Saudi Pharmaceutical Journal 29 (2), pp.206-212. (10.1016/j.jsps.2021.01.004)
- Orayj, K. et al. 2019. Association between levodopa and ischemic heart disease. International Journal of Population Data Science 4 (3) 011. (10.23889/ijpds.v4i3.1172)
- De Vis, P. et al., 2017. Herschel-ATLAS: revealing dust build-up and decline across gas, dust and stellar mass selected samples – I. Scaling relations. Monthly Notices of the Royal Astronomical Society 464 (4), pp.4680-4705. (10.1093/mnras/stw2501)
- Jenkins, A. I. et al. 2016. Too far away to work with each other: Does location impact on pharmacists' perceptions of interprofessional interactions?. Journal of Interprofessional Care 30 (5), pp.678-681. (10.1080/13561820.2016.1191451)
- Aljayyoussi, G. et al., 2015. Absorption of ipratropium and L-carnitine into the pulmonary circulation of the ex-vivo rat lung is driven by passive processes rather than active uptake by OCT/OCTN transporters. International Journal of Pharmaceutics 496 (2), pp.834-841. (10.1016/j.ijpharm.2015.10.036)
- Aljayyoussi, G. et al. 2013. Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: A study in ex vivo lung models using chemical inhibition and genetic knockout. Journal of Pharmaceutical Sciences 102 (9), pp.3382-3394. (10.1002/jps.23587)
- Campbell, L. et al. 2013. Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease. Journal of Translational Medicine 11 (1) 255. (10.1186/1479-5876-11-255)
- Smith, M. W. , Aljayyoussi, G. and Gumbleton, M. 2012. Peptide sequences mediating tropism to intact blood-brain barrier: An in vivo biodistribution study using phage display. Peptides 38 (1), pp.172-180. (10.1016/j.peptides.2012.06.019)
- Gumbleton, M. et al. 2011. Spatial expression and functionality of drug transporters in the intact lung: objectives for further research. Advanced Drug Delivery Reviews 63 (1-2), pp.110-118. (10.1016/j.addr.2010.09.008)
- Morris, C. J. et al. 2011. Enhanced pulmonary absorption of a macromolecule through coupling to a sequence-specific phage display-derived peptide. Journal of Controlled Release 151 (1), pp.83-94. (10.1016/j.jconrel.2010.12.003)
- Barar, J. et al., 2007. Cell selective glucocorticoid induction of caveolin-1 and caveolae in differentiating pulmonary alveolar epithelial cell cultures. Biochemical and Biophysical Research Communications 359 (2), pp.360-366. (10.1016/j.bbrc.2007.05.106)
- Smith, M. W. , Omidi, Y. and Gumbleton, M. 2007. Primary porcine brain microvascular endothelial cells: Biochemical and functional characterisation as a model for drug transport and targeting. Journal of Drug Targeting 15 (4), pp.253-268. (10.1080/10611860701288539)
- Smith, M. W. and Gumbleton, M. 2006. Endocytosis at the blood-brain barrier: From basic understanding to drug delivery strategies. Journal of Drug Targeting 14 (4), pp.191-214. (10.1080/10611860600650086)
Book sections
- Smith, M. W. , Birchall, J. C. and Coulman, S. 2011. The wider contribution of microbiology to the pharmaceutical sciences. In: Denver, S. P. et al., Hugo and Russell's Pharmaceutical Microbiology 8th Edition. Wiley-Blackwell. , pp.463-482.
Conferences
- Johnson, I. et al. 2017. Learning how "professions can work together to provide the best care": Dental-pharmacy inter-professional education presenter. Presented at: Learning together to improve oral health and quality of life Vilnius, Lithuania 23-26 August 2017. , pp.45-45.
Thesis
- Smith, M. W. 2009. Phage display and experimental brain therapeutics. PhD Thesis , Cardiff University.
Research
Research interests
- Blood Brain Barrier
- Phage Display
- Experimental Therapeutics
Teaching
Contribute to lecturing/research projects across MPharm degree course:
- PH1121 Molecule to patient
- PH1122 The role of the pharmacist in professional practice
- PH1124 Human body systems
- PH1125 Chemical and biological properties of drug molecules
- PH2110 Clinical & professional pharmacy
- PH2113 Diseases and drugs I
- PH2203 Drug disposition
- PH3110 Optimisation of pharmaceutical care
- PH3113 Diseases and drugs II
- PH4116 Pharmacy research or scholarship project
- PH4117 Pharmaceutical sciences, pharmacy practice and the population
- PH4118 Pharmaceutical sciences, pharmacy practice and the patient
